An Observational Study of Lumosity in Seniors

May 23, 2017 updated by: Lumos Labs, Inc.
The primary objective of this observational study is to determine performance characteristics and usability of Lumosity and the Brain Performance Test in a group of older adult volunteers.

Study Overview

Status

Completed

Conditions

Detailed Description

Approximately 200 prospective users currently will be provided free 6-month premium access Lumosity accounts. Participants will be provided with an account activation code and instructed on how to sign up for Lumosity with their email address. They will be subject to the Lumosity Terms of Service and follow the typical user experience. Upon creating an account, users would be asked to complete a short demographic survey that includes questions on gender, education, occupation, years since retirement, health, computer familiarity, and perceptions of brain training.

Those who sign up will have immediate access to the Lumosity training system and the entire suite of Lumosity games. In addition, they will be invited, via email, to take the Brain Performance Test one week after the initial sign-up and then again 12 weeks later. Approximately every 8 weeks, users will be asked to complete a short questionnaire about their experience with Lumosity. This questionnaire will be accessed via email. Participants will be asked to train 5 days a week for 20-30 minutes per day, but are free to play as much or a little as they choose. Community associates at the sites will be encouraged to host group training sessions, giving the seniors a chance to gather and complete their training together, share their experiences, and get any help they may need. In addition, sites will have the option of hosting 1-2 focus groups with participants and researchers from Lumos Labs. The focus groups will be an opportunity to give and receive direct feedback about Lumosity, and get any questions answered by the researchers.

Study Type

Observational

Enrollment (Actual)

68

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94105
        • Lumos Labs, Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants must be cognitively stable older adult volunteers(over 55 years of age)

Description

Inclusion Criteria:

Participants must meet the following criteria:

  1. 55 years of age or older
  2. English-speaker
  3. Cognitively stable (i.e., without a known diagnosis that may affect cognitive abilities)
  4. Regular access to and ability to use a computer or mobile device with Internet connectivity.

Exclusion Criteria:

  1. Under 55 years of age
  2. Have a current diagnosed cognitive or neuropsychological condition
  3. Are taking medication that may impede cognitive functioning
  4. Anticipate a dosage change in medication that may affect cognitive functioning during the course of the study (24 weeks)
  5. Have other conditions or problems that may preclude regular computer usage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usability - as measured by self-report feedback surveys
Time Frame: Change from Baseline - collected at baseline, 3 months and 6 months
Using self-report surveys administered to participants at baseline, 3 months and 6 months, investigators will calculate a usability score of Lumosity.
Change from Baseline - collected at baseline, 3 months and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
User Engagement - as measured by number of unique days played
Time Frame: 6 months
Calculating the number of unique days played will allow us to estimate the engagement level of study participants.
6 months
Change from baseline on the Lumosity Performance Index (LPI)
Time Frame: Change from Baseline - collected at baseline and 6 months
To evaluate the Lumosity Performance Index (LPI) results in a group of seniors
Change from Baseline - collected at baseline and 6 months
Change from baseline on the Brain Performance Test (BPT)
Time Frame: Change from Baseline - collected at baseline, 3 months and 6 months
To evaluate the Brain Performance Test (BPT) results in a group of seniors
Change from Baseline - collected at baseline, 3 months and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Glenn Morrison, PhD, Lumos Labs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

May 23, 2017

Study Completion (Actual)

May 23, 2017

Study Registration Dates

First Submitted

November 18, 2015

First Submitted That Met QC Criteria

November 23, 2015

First Posted (Estimate)

November 25, 2015

Study Record Updates

Last Update Posted (Actual)

May 25, 2017

Last Update Submitted That Met QC Criteria

May 23, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • LL004

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

3
Subscribe